NSCLC丨FDA批准首个针对EGFR ex20ins突变靶向药物,G360 CDx成伴随诊断!( 三 )

7.Bauml JM et al., Underdiagnosis of EGFR exon 20 insertion mutation variants: estimates from NGS-based real-world datasets. WCLCL 2020, FP07.12